back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2017-12-06 Tx date 2017-10-27 |
$MQ
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of C$0.10; Expiry: October 27, 2017.
55 - Expiration of warrants
|
-31,333 vol |
0 | |
| Filed 2017-10-23 Tx date 2017-02-22 |
$MQ
Callitas Health Inc. |
Rodgers, William A.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-23 Tx date 2017-10-17 |
$MQ
Callitas Health Inc. |
Rodgers, William A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2017-10-23 Tx date 2017-02-22 |
$MQ
Callitas Health Inc. |
Rodgers, William A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
| Filed 2017-10-20 Tx date 2017-03-06 |
$MQ
Callitas Health Inc. |
Whittemore, Kim Elizabeth
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-20 Tx date 2017-03-06 |
$MQ
Callitas Health Inc. |
Whittemore, Kim Elizabeth
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-20 Tx date 2017-10-17 |
$MQ
Callitas Health Inc. |
Thompson, James M.
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
130,000 | |
| Filed 2017-10-20 Tx date 2017-10-17 |
$MQ
Callitas Health Inc. |
Thompson, Gary A.
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
280,000 | |
| Filed 2017-10-20 Tx date 2017-10-17 |
$MQ
Callitas Health Inc. |
Stephens, Gary
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
| Filed 2017-10-20 Tx date 2017-06-08 |
$MQ
Callitas Health Inc. |
Stephens, Gary
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-20 Tx date 2017-10-17 |
$MQ
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
300,000 | |
| Filed 2017-10-20 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.08; Expiry: September 7, 2018
37 - Stock split or consolidation
|
$-2,880
-36,000 vol $0.08 each |
4,000 | |
| Filed 2017-10-20 Tx date 2017-10-17 |
$MQ
Callitas Health Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
280,000 | |
| Filed 2017-10-20 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$-57,600
-720,000 vol $0.08 each |
180,000 | |
| Filed 2017-10-20 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$-57,600
-720,000 vol $0.08 each |
900,000 | |
| Filed 2017-10-20 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$-30,600
-180,000 vol $0.17 each |
1,620,000 | |
| Filed 2017-10-20 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-36,000 vol |
4,000 | |
| Filed 2017-10-20 Tx date 2016-09-07 |
$MQ
M Pharmaceutical Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
10% Convertible Debentures due September 7, 2019
16 - Acquisition or disposition under a prospectus exemption
|
+$10,000 vol |
$10,000 | |
| Filed 2017-10-20 Tx date 2016-09-07 |
$MQ
M Pharmaceutical Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
10% Convertible Debentures due September 7, 2019
16 - Acquisition or disposition under a prospectus exemption
|
+$10,000 vol |
||
| Filed 2017-10-20 Tx date 2017-10-17 |
$MQ
Callitas Health Inc. |
Whittemore, Kim Elizabeth
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2017-10-17 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Stephens, Gary
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-11,250 vol |
1,250 | |
| Filed 2017-10-13 Tx date 2017-10-10 |
$MQ
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$25,000
+100,000 vol $0.25 each |
283,709 | |
| Filed 2017-10-13 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of C$0.10; Expiry: October 27, 2017.
37 - Stock split or consolidation
|
$-28,199.90
-281,999 vol $0.10 each |
31,333 | |
| Filed 2017-10-13 Tx date 2017-10-10 |
$MQ
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.50; Expiry: October 10, 2018
36 - Conversion or exchange
|
+100,000 vol |
100,000 | |
| Filed 2017-10-13 Tx date 2014-12-02 |
$MQ
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.50; Expiry: October 10, 2018
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-13 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.25; Expiry: February 10, 2020.
37 - Stock split or consolidation
|
$-72,000
-288,000 vol $0.25 each |
32,000 | |
| Filed 2017-10-13 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$-72,000
-900,000 vol $0.08 each |
200,000 | |
| Filed 2017-10-13 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$-57,600
-720,000 vol $0.08 each |
1,100,000 | |
| Filed 2017-10-13 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$-30,600
-180,000 vol $0.17 each |
1,820,000 | |
| Filed 2017-10-13 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$-30,600
-180,000 vol $0.17 each |
||
| Filed 2017-10-13 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$-30,600
-180,000 vol $0.17 each |
||
| Filed 2017-10-13 Tx date 2017-10-10 |
$MQ
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures due October 27, 2018
36 - Conversion or exchange
|
$
-$25,000 vol $0.25 each |
$0 | |
| Filed 2017-10-13 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Holder: D R Skeith Professional Corp. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-1,857,600 vol |
206,400 | |
| Filed 2017-10-13 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,653,381 vol |
183,709 | |
| Filed 2017-09-22 Tx date 2017-09-18 |
$MQ
Callitas Health Inc. |
Thompson, Gary A.
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$125,000
+250,000 vol $0.50 each |
1,061,667 | |
| Filed 2017-09-22 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Thompson, James M.
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$-57,600
-720,000 vol $0.08 each |
80,000 | |
| Filed 2017-09-22 Tx date 2017-02-28 |
$MQ
Callitas Health Inc. |
Thompson, James M.
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
800,000 | ||
| Filed 2017-09-22 Tx date 2017-09-18 |
$MQ
Callitas Health Inc. |
Thompson, James M.
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$533,333
+1,066,666 vol $0.50 each |
3,444,759 | |
| Filed 2017-09-22 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Thompson, James M.
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-21,402,830 vol |
2,378,093 | |
| Filed 2017-09-22 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Thompson, James M.
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-19,200,035 vol |
||
| Filed 2017-09-22 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Thompson, James M.
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-19,200,035 vol |
||
| Filed 2017-09-22 Tx date 2017-02-28 |
$MQ
Callitas Health Inc. |
Thompson, James M.
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
23,780,923 | ||
| Filed 2017-09-22 Tx date 2017-02-28 |
$MQ
Callitas Health Inc. |
Thompson, James M.
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-22 Tx date 2017-02-28 |
$MQ
Callitas Health Inc. |
Thompson, James M.
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-22 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Thompson, Gary A.
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$-72,000
-900,000 vol $0.08 each |
180,000 | |
| Filed 2017-09-22 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Thompson, Gary A.
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$-57,600
-720,000 vol $0.08 each |
1,080,000 | |
| Filed 2017-09-22 Tx date 2017-09-12 |
$MQ
Callitas Health Inc. |
Thompson, Gary A.
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-7,304,999 vol |
811,667 | |
| Filed 2017-08-16 Tx date 2017-08-15 |
$MQ
M Pharmaceutical Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$43,555
+1,088,880 vol $0.04 each |
||
| Filed 2017-08-16 Tx date 2017-08-15 |
$MQ
M Pharmaceutical Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Holder: D R Skeith Professional Corp. (Indirect Ownership)
|
Warrants at an exercise price of $0.05; Expiry: June 27, 2017
54 - Exercise of warrants
|
$-50,000
-1,000,000 vol $0.05 each |
0 | |
| Filed 2017-08-16 Tx date 2017-08-15 |
$MQ
M Pharmaceutical Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Holder: D R Skeith Professional Corp. (Indirect Ownership)
|
Warrants at an exercise price of $0.05; Expiry: June 27, 2017
11 - Acquisition or disposition carried out privately
|
-1,000,000 vol |
||
| Filed 2017-08-16 Tx date 2017-08-15 |
$MQ
M Pharmaceutical Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Holder: D R Skeith Professional Corp. (Indirect Ownership)
|
Warrants at an exercise price of $0.05; Expiry: June 27, 2017
11 - Acquisition or disposition carried out privately
|
-1,000,000 vol |
||
| Filed 2017-08-16 Tx date 2017-08-15 |
$MQ
M Pharmaceutical Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.05; Expiry: June 27, 2017
11 - Acquisition or disposition carried out privately
|
-1,088,880 vol |
0 | |
| Filed 2017-08-16 Tx date 2017-08-15 |
$MQ
M Pharmaceutical Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.05; Expiry: June 27, 2017
54 - Exercise of warrants
|
$-43,555.20
-1,088,880 vol $0.04 each |
||
| Filed 2017-08-16 Tx date 2017-08-15 |
$MQ
M Pharmaceutical Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.05; Expiry: June 27, 2017
54 - Exercise of warrants
|
$-43,555.20
-1,088,880 vol $0.04 each |
||
| Filed 2017-08-16 Tx date 2017-08-15 |
$MQ
M Pharmaceutical Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Holder: D R Skeith Professional Corp. (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$50,000
+1,000,000 vol $0.05 each |
2,064,000 | |
| Filed 2017-08-16 Tx date 2017-08-15 |
$MQ
M Pharmaceutical Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$43,555
+1,088,880 vol $0.04 each |
||
| Filed 2017-06-12 Tx date 2017-06-08 |
$MQ
M Pharmaceutical Inc. |
Stephens, Gary
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
12,500 | ||
| Filed 2017-04-26 Tx date 2017-04-26 |
$MQ
M Pharmaceutical Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.05; Expiry: February 6, 2017.
54 - Exercise of warrants
|
$-1,250
-25,000 vol $0.05 each |
0 | |
| Filed 2017-04-26 Tx date 2017-04-26 |
$MQ
M Pharmaceutical Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$1,250
+25,000 vol $0.05 each |
1,837,090 | |
| Filed 2017-02-14 Tx date 2016-11-08 |
$MQ
M Pharmaceutical Inc. |
Thompson, Gary A.
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$198,333
+5,666,666 vol $0.035 each |
8,116,666 | |
| Filed 2017-02-14 Tx date 2017-01-26 |
$MQ
M Pharmaceutical Inc. |
Thompson, Gary A.
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,800,000 | |
| Filed 2017-02-14 Tx date 2016-08-02 |
$MQ
M Pharmaceutical Inc. |
Thompson, Gary A.
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
800,000 | ||
| Filed 2017-02-14 Tx date 2016-08-02 |
$MQ
M Pharmaceutical Inc. |
Thompson, Gary A.
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,450,000 | ||
| Filed 2017-01-30 Tx date 2017-01-26 |
$MQ
M Pharmaceutical Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+800,000 vol |
1,800,000 | |
| Filed 2017-01-30 Tx date 2017-01-26 |
$MQ
M Pharmaceutical Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
2,000,000 | |
| Filed 2017-01-30 Tx date 2017-01-26 |
$MQ
M Pharmaceutical Inc. |
Kovaleva, Tatiana
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
750,000 | |
| Filed 2017-01-30 Tx date 2017-01-26 |
$MQ
M Pharmaceutical Inc. |
Keane, Brian D.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
1,200,000 | |
| Filed 2017-01-30 Tx date 2017-01-26 |
$MQ
M Pharmaceutical Inc. |
Tsafalas, George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
2,050,000 | |
| Filed 2016-09-11 Tx date 2015-05-14 |
$MQ
M Pharmaceutical Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
10% Convertible Debentures due September 7, 2019
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-11 Tx date 2016-09-07 |
$MQ
M Pharmaceutical Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.08; Expiry: September 7, 2018
16 - Acquisition or disposition under a prospectus exemption
|
+40,000 vol |
40,000 | |
| Filed 2016-09-11 Tx date 2015-05-14 |
$MQ
M Pharmaceutical Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.08; Expiry: September 7, 2018
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-11 Tx date 2016-09-07 |
$MQ
M Pharmaceutical Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+40,000 vol |
40,000 | |
| Filed 2016-09-11 Tx date 2015-05-14 |
$MQ
M Pharmaceutical Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-11 Tx date 2016-09-07 |
$MQ
M Pharmaceutical Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
10% Convertible Debentures due September 7, 2019
16 - Acquisition or disposition under a prospectus exemption
|
+$10,000 vol |
$10,000 | |
| Filed 2016-07-26 Tx date 2016-04-04 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Keane, Brian D.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-07-26 Tx date 2016-07-25 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+800,000 vol |
1,000,000 | |
| Filed 2016-07-26 Tx date 2016-07-25 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Keane, Brian D.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+800,000 vol |
800,000 | |
| Filed 2016-07-26 Tx date 2016-07-25 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Kovaleva, Tatiana
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
450,000 | |
| Filed 2016-07-26 Tx date 2016-07-25 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+800,000 vol |
1,000,000 | |
| Filed 2016-07-26 Tx date 2016-07-25 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+800,000 vol |
1,050,000 | |
| Filed 2016-07-03 Tx date 2016-04-04 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Keane, Brian D.
5 - Senior Officer of Issuer
Holder: Joseph Breman and Brian Keane (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-07-03 Tx date 2015-10-31 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Direct Ownership
|
Warrants re-priced to C$0.13; Expiry: 09-13-15 extended to 10-31-15
55 - Expiration of warrants
|
-100,000 vol |
0 | |
| Filed 2016-07-03 Tx date 2016-06-30 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Holder: Tsafalas Enterprises Inc. (Indirect Ownership)
|
Warrants at an exercise price of $0.05; Expiry: June 27, 2017
36 - Conversion or exchange
|
$58,689
+2,347,560 vol $0.025 each |
2,347,560 | |
| Filed 2016-07-03 Tx date 2013-06-28 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Holder: Tsafalas Enterprises Inc. (Indirect Ownership)
|
Warrants at an exercise price of $0.05; Expiry: June 27, 2017
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-07-03 Tx date 2016-06-30 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.05; Expiry: June 27, 2017
36 - Conversion or exchange
|
$25,238
+1,009,520 vol $0.025 each |
1,009,520 | |
| Filed 2016-07-03 Tx date 2013-06-28 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.05; Expiry: June 27, 2017
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-07-03 Tx date 2016-06-18 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.05; Expiry: June 18, 2016.
55 - Expiration of warrants
|
-50,000 vol |
0 | |
| Filed 2016-07-03 Tx date 2016-06-30 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Holder: Tsafalas Enterprises Inc. (Indirect Ownership)
|
Convertible Debentures due October 27, 2018
36 - Conversion or exchange
|
$
-$58,689 vol $0.025 each |
$0 | |
| Filed 2016-07-03 Tx date 2016-06-30 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures due October 27, 2018
36 - Conversion or exchange
|
$
-$25,238 vol $0.025 each |
$0 | |
| Filed 2016-07-03 Tx date 2016-06-30 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Holder: Tsafalas Enterprises Inc. (Indirect Ownership)
|
Common Shares
36 - Conversion or exchange
|
$58,689
+2,347,560 vol $0.025 each |
3,372,223 | |
| Filed 2016-07-03 Tx date 2016-06-30 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$25,238
+1,009,520 vol $0.025 each |
2,579,889 | |
| Filed 2016-07-03 Tx date 2016-06-30 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.05; Expiry: June 27, 2017
36 - Conversion or exchange
|
$27,222
+1,088,880 vol $0.025 each |
1,088,880 | |
| Filed 2016-07-03 Tx date 2014-12-02 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.05; Expiry: June 27, 2017
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-07-03 Tx date 2016-06-18 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.05; Expiry: June 18, 2016.
55 - Expiration of warrants
|
-60,825 vol |
0 | |
| Filed 2016-07-03 Tx date 2016-06-30 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures due October 27, 2018
36 - Conversion or exchange
|
$
-$27,222 vol $0.025 each |
$25,000 | |
| Filed 2016-07-03 Tx date 2016-06-30 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$27,222
+1,088,880 vol $0.025 each |
1,812,090 | |
| Filed 2016-07-03 Tx date 2016-06-30 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Keane, Brian D.
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.05; Expiry: June 27, 2017
36 - Conversion or exchange
|
$5,200
+208,000 vol $0.025 each |
852,390 | |
| Filed 2016-07-03 Tx date 2016-06-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Keane, Brian D.
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.05; Expiry: June 27, 2017
16 - Acquisition or disposition under a prospectus exemption
|
$16,109
+644,390 vol $0.025 each |
644,390 | |
| Filed 2016-07-03 Tx date 2016-04-04 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Keane, Brian D.
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.05; Expiry: June 27, 2017
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-07-03 Tx date 2016-06-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Keane, Brian D.
5 - Senior Officer of Issuer
Holder: Joseph Breman and Brian Keane (Control or Direction)
|
Warrants at an exercise price of $0.05; Expiry: June 27, 2017
16 - Acquisition or disposition under a prospectus exemption
|
$32,219
+1,288,789 vol $0.025 each |
1,288,789 | |
| Filed 2016-07-03 Tx date 2016-04-04 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Keane, Brian D.
5 - Senior Officer of Issuer
Holder: Joseph Breman and Brian Keane (Control or Direction)
|
Warrants at an exercise price of $0.05; Expiry: June 27, 2017
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-07-03 Tx date 2016-06-30 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Keane, Brian D.
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures due October 27, 2018
36 - Conversion or exchange
|
$
-$5,200 vol $0.025 each |
$0 | |
| Filed 2016-07-03 Tx date 2016-04-04 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Keane, Brian D.
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures due October 27, 2018
00 - Opening Balance-Initial SEDI Report
|
$5,200 | ||
| Filed 2016-07-03 Tx date 2016-06-30 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Keane, Brian D.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$5,200
+208,000 vol $0.025 each |
1,113,590 | |
| Filed 2016-07-03 Tx date 2016-06-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Keane, Brian D.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$16,109
+644,390 vol $0.025 each |
905,590 | |
| Filed 2016-07-03 Tx date 2016-04-04 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Keane, Brian D.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
261,200 | ||
| Filed 2016-07-03 Tx date 2016-06-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Keane, Brian D.
5 - Senior Officer of Issuer
Holder: Joseph Breman and Brian Keane (Control or Direction)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$32,219
+1,288,789 vol $0.025 each |
1,288,789 | |
| Filed 2016-06-30 Tx date 2016-06-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Holder: D R Skeith Professional Corp. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+1,000,000 vol $0.025 each |
1,064,000 | |
| Filed 2016-06-30 Tx date 2016-06-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Holder: D R Skeith Professional Corp. (Indirect Ownership)
|
Warrants at an exercise price of $0.05; Expiry: June 27, 2017
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+1,000,000 vol $0.025 each |
1,000,000 | |
| Filed 2016-06-30 Tx date 2014-12-02 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Holder: D R Skeith Professional Corp. (Indirect Ownership)
|
Warrants at an exercise price of $0.05; Expiry: June 27, 2017
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-04-14 Tx date 2016-04-13 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,000
-200,000 vol $0.025 each |
1,570,369 | |
| Filed 2015-10-27 Tx date 2015-09-01 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Lehman, Matthew Bryson
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants at an exercise price of C$0.10; Expiry: October 27, 2017.
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-27 Tx date 2015-10-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Holder: Tsafalas Enterprises Inc. (Indirect Ownership)
|
Warrants at an exercise price of C$0.10; Expiry: October 27, 2017.
16 - Acquisition or disposition under a prospectus exemption
|
+352,134 vol |
352,134 | |
| Filed 2015-10-27 Tx date 2013-06-28 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Holder: Tsafalas Enterprises Inc. (Indirect Ownership)
|
Warrants at an exercise price of C$0.10; Expiry: October 27, 2017.
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-27 Tx date 2015-10-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of C$0.10; Expiry: October 27, 2017.
16 - Acquisition or disposition under a prospectus exemption
|
+151,428 vol |
151,428 | |
| Filed 2015-10-27 Tx date 2013-06-28 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of C$0.10; Expiry: October 27, 2017.
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-27 Tx date 2015-10-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Holder: Tsafalas Enterprises Inc. (Indirect Ownership)
|
Convertible Debentures due October 27, 2018
16 - Acquisition or disposition under a prospectus exemption
|
+$58,689 vol |
$58,689 | |
| Filed 2015-10-27 Tx date 2013-06-28 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Holder: Tsafalas Enterprises Inc. (Indirect Ownership)
|
Convertible Debentures due October 27, 2018
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-27 Tx date 2015-10-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures due October 27, 2018
16 - Acquisition or disposition under a prospectus exemption
|
+$25,238 vol |
$25,238 | |
| Filed 2015-10-27 Tx date 2013-06-28 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures due October 27, 2018
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-27 Tx date 2015-10-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Holder: Tsafalas Enterprises Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+352,134 vol |
1,024,663 | |
| Filed 2015-10-27 Tx date 2015-10-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+151,428 vol |
1,770,369 | |
| Filed 2015-10-27 Tx date 2015-10-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of C$0.10; Expiry: October 27, 2017.
16 - Acquisition or disposition under a prospectus exemption
|
+313,332 vol |
313,332 | |
| Filed 2015-10-27 Tx date 2014-12-02 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of C$0.10; Expiry: October 27, 2017.
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-27 Tx date 2015-10-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures due October 27, 2018
16 - Acquisition or disposition under a prospectus exemption
|
+$52,222 vol |
$52,222 | |
| Filed 2015-10-27 Tx date 2014-12-02 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures due October 27, 2018
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-27 Tx date 2015-10-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+313,332 vol |
723,210 | |
| Filed 2015-10-27 Tx date 2015-10-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Lehman, Matthew Bryson
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants at an exercise price of C$0.10; Expiry: October 27, 2017.
16 - Acquisition or disposition under a prospectus exemption
|
+486,000 vol |
486,000 | |
| Filed 2015-10-27 Tx date 2015-10-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Lehman, Matthew Bryson
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures due October 27, 2018
16 - Acquisition or disposition under a prospectus exemption
|
+$81,000 vol |
$81,000 | |
| Filed 2015-10-27 Tx date 2015-09-01 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Lehman, Matthew Bryson
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures due October 27, 2018
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-27 Tx date 2015-10-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Lehman, Matthew Bryson
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+486,000 vol |
2,486,000 | |
| Filed 2015-09-16 Tx date 2015-09-01 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Lehman, Matthew Bryson
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-09-16 Tx date 2015-09-15 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Lehman, Matthew Bryson
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
400,000 | |
| Filed 2015-09-16 Tx date 2015-09-01 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Lehman, Matthew Bryson
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-09-16 Tx date 2015-09-11 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Lehman, Matthew Bryson
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$165,000
+2,000,000 vol $0.0825 each |
2,000,000 | |
| Filed 2015-06-19 Tx date 2015-06-15 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2015-06-19 Tx date 2015-06-15 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
250,000 | |
| Filed 2015-06-19 Tx date 2013-06-28 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-19 Tx date 2015-05-14 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-05-11 Tx date 2015-05-08 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Kovaleva, Tatiana
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
| Filed 2015-05-11 Tx date 2015-05-08 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Holder: Tsafalas Enterprises Inc. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$103,449
+608,529 vol $0.17 each |
672,529 | |
| Filed 2015-05-11 Tx date 2015-05-08 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2015-05-11 Tx date 2014-12-02 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-05-11 Tx date 2015-05-08 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Mintchev, Martin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
300,000 | |
| Filed 2015-05-11 Tx date 2014-12-02 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Mintchev, Martin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-05-11 Tx date 2014-01-13 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Kovaleva, Tatiana
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-04-30 Tx date 2014-12-02 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.25; Expiry: February 10, 2020.
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-04-30 Tx date 2015-04-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.25; Expiry: February 10, 2020.
16 - Acquisition or disposition under a prospectus exemption
|
+1,120,000 vol |
1,120,000 | |
| Filed 2015-04-30 Tx date 2013-06-28 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.25; Expiry: February 10, 2020.
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-04-30 Tx date 2015-04-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Holder: Tsafalas Enterprises Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$16,000
+64,000 vol $0.25 each |
64,000 | |
| Filed 2015-04-30 Tx date 2013-06-28 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Holder: Tsafalas Enterprises Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-04-30 Tx date 2015-04-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Tsafalas, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$284,800
+1,139,200 vol $0.25 each |
1,618,941 | |
| Filed 2015-04-30 Tx date 2015-04-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.25; Expiry: February 10, 2020.
16 - Acquisition or disposition under a prospectus exemption
|
+320,000 vol |
320,000 | |
| Filed 2015-04-30 Tx date 2015-04-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Mintchev, Martin
4 - Director of Issuer
Holder: EatLittle Inc. (Control or Direction)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$875,000
+3,500,000 vol $0.25 each |
3,500,000 | |
| Filed 2015-04-30 Tx date 2015-04-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$80,000
+320,000 vol $0.25 each |
409,878 | |
| Filed 2015-04-30 Tx date 2015-04-27 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Holder: D R Skeith Professional Corp. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$16,000
+64,000 vol $0.25 each |
64,000 | |
| Filed 2015-04-30 Tx date 2014-12-02 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Skeith, Donald Richard
4 - Director of Issuer
Holder: D R Skeith Professional Corp. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-04-30 Tx date 2014-12-02 |
$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) |
Mintchev, Martin
4 - Director of Issuer
Holder: EatLittle Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|